We only have this paper's title and publication details.
Read it at the sourceScientific correspondence clarifies the role of SLC25A1 in metabolic reprogramming in acute myeloid leukemia cells, highlighting mitochondrial pathways as potential therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: